Spinal Muscular Atrophy Trial, Recruiting NCT03940911 Sponsor: University Hospital, Strasbourg, France Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT03940911
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with axial spondyloarthritis (a type of inflammatory spine condition) according to specific medical classification guidelines (confirm with trial site)
  • You have never previously been treated with a "targeted therapy" (a specific type of modern medication for inflammatory conditions)
  • Your doctor has decided you need to start a targeted therapy
  • You have started your targeted therapy no more than 15 days before joining the trial
  • You are 18 years old or older (there is no upper age limit)
  • You are covered by a social health insurance plan
  • You are able to understand what the study involves and have signed a consent form
  • You have been informed of the results of your initial medical check-up
  • If you are a woman who could become pregnant, you have had a negative pregnancy test and are using effective contraception
  • You have a sufficient understanding of French to follow the study procedures

Who may not be able to join:

  • You have already been on a targeted therapy for more than 15 days before joining the trial
  • You have a medical reason why you cannot take targeted therapy
  • You have taken steroid tablets or injections (such as cortisone) in the 15 days before your first study visit
  • You have another inflammatory disease affecting internal organs, such as inflammatory bowel disease (excluding eye or skin involvement)
  • You have fibromyalgia, based on a specific questionnaire score taken at your first visit (confirm with trial site)
  • You have a history of heart problems, such as chest pain on exertion, a heart attack, or a procedure to open blocked heart arteries
  • You have a history of blocked arteries in your legs, causing leg pain when walking, or you have had a procedure to open leg arteries
  • You have chronic obstructive pulmonary disease (a long-term lung condition)
  • You have a condition affecting your nerves or muscles
  • You have significant problems with how your kidneys, liver, lungs, or heart are working
  • You have sleep apnea (a condition where breathing repeatedly stops during sleep)
  • It is not possible to properly inform you about the study (for example, due to a language barrier or emergency situation)
  • You are currently under legal protection measures (confirm with trial site)
  • You are under guardianship or a similar legal arrangement
  • You are currently breastfeeding
  • You are currently pregnant
  • You are already taking part in another clinical trial, or are within a waiting period after a previous clinical trial, that could affect this study's results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 3 88 11 67 68

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 November 2025
Est. completion
1 December 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Oxygen consumption capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov